mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-07 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-07 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |